title: Isotretinoin and iPledge: a view of results.
authors.affiliation: University of Massachusetts Medical School, Worcester, Massachusetts. Electronic address: maloneym@ummhc.org.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Maloney
authors.affiliation: Southern Illinois University School of Medicine, Springfield, Illinois.
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Stone
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000517:prevention & control*; D016730:Program Development; D015397:Program Evaluation; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D003879:Dermatologic Agents; D015474:Isotretinoin